A new study conducted by the Nova Institute and HempConsult regarding the growing market for industrial hemp foods and beverages reveals the immense market for the non-psychoactive cannabinoid CBD as a nutritional supplement and for medicinal uses.
Industrial hemp field figures rose from only 8.000 ha in 2011 to 25.000ha in 2015, due to rising demands in the food, food supplement and pharmaceutical industries thanks to industrial hemp’s reputation as a superfood. Which is why we believe in GreenSnake® Hemp Juice!
The study states that CBD as a medicine has the potential of a 2 billion € per annum profit in Europe alone, with an estimated minimum of 24 million € annually. With the main focus on treating for instance epilepsy, anxiety disorders, ADHD, schizophrenia, inflammation-related illnesses etc.
What we need is further scientific research being conducted, raising general public awareness and investments in the development of this newly emerging market. GreenSnake® Hemp Juice is very excited about this!
We look forward to the presentation of these two new studies at the „13th International Conference of the European Industrial Hemp Association“, which will take place in Cologne on the 1st and 2nd of June 2016. 250 industrial hemp experts such as myself will be attening the conference which is the worldwide largest one of its kind.
We are excited to discuss all new findings with our fellow hemp folks and network to bring the best outcome to everyone!
Happy hemping everyone!